Aggressive Malpractice Environment Ups Hospital LOS

This article originally appeared here.
Share this content:
Aggressive Malpractice Environment Ups Hospital LOS
Aggressive Malpractice Environment Ups Hospital LOS

FRIDAY, June 19, 2015 (HealthDay News) -- An aggressive malpractice environment is associated with increased hospitalization charges and length of stay for patients undergoing spine surgery, according to a study published in the July 1 issue of The Spine Journal.

Symeon Missios, M.D., from Louisiana State University in Shreveport, and Kimon Bekelis, M.D., from the Dartmouth-Hitchcock Medical Center in Lebanon, N.H., examined the correlation of malpractice liability with unfavorable outcomes in spine surgery. Data were included for 707,951 patients undergoing spine surgery who were registered in the Nationwide Inpatient Sample database from 2005 to 2010. Measures of volume and size of malpractice claim payments were created using data from the National Practitioner Data Bank.

In multivariable regression analysis, the researchers observed a correlation for higher number of claims per 100 physicians in a state with increased hospitalization charges and length of stay. No correlation was seen for mortality (odds ratio, 0.99; 95 percent confidence interval, 0.87 to 1.12). Larger magnitude of awarded claims correlated with increased hospitalization charges and length of stay, but there was no correlation with mortality (odds ratio, 0.95; 95 percent confidence interval, 0.82 to 1.11).

"Aggressive malpractice environment was not correlated with mortality but was associated with higher hospitalization charges after spine surgery," the authors write. "Further research is needed to identify ways to regulate the malpractice system to address these disparities."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »